Analisis Keuangan Saham BNR - Burning Rock Biotech Limited - Depositary Receipt (Common Stock) (NasdaqGM) Stock

Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ DE000A1DAHH0

Gambaran Umum
Ang Burning Rock Biotech Limited ay isang kumpanyang naka-headquarter sa China, na pangunahing tumatakbo sa loob ng industriya ng biotechnology. Dalubhasa ang kumpanya sa mga solusyon sa precision oncology, na tumutuon sa mga diagnostic ng susunod na henerasyon na sequencing (NGS). Ang kanilang mga pangunahing proyekto ay nagsasangkot ng pagbuo at pagkomersyal ng isang hanay ng mga pagsubok at mga therapy na iniayon sa mga genetic na profile ng mga indibidwal na pasyente ng kanser. Ang Burning Rock Biotech ay malapit na nakikipagtulungan sa mga pandaigdigang kumpanya ng parmasyutiko at mga institusyong medikal upang isulong ang pagiging epektibo ng pananaliksik at paggamot sa kanser. Ang kanilang mga pagsusumikap ay higit na nakasentro sa pagbibigay ng komprehensibong genomic profiling na mga pagsubok upang matukoy ang mga mutasyon sa kanser, kaya pinapadali ang mga naka-target na desisyon sa therapy at pagpapabuti ng mga resulta ng paggamot para sa mga pasyente na may iba't ibang uri ng kanser.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
  • Nilai revenue untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah 523.28 MM.
  • Nilai operating income untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -211.78 MM.
  • Nilai net income untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -238.58 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-03-31 523.28 -211.78 -238.58
2024-12-31 515.82 -322.43 -346.63
2024-09-30 510.88 -441.96 -427.55
2024-06-30 509.81 -582.18 -566.78
2024-03-31 520.54 -606.69 -589.99
2023-12-31 537.43 -669.32 -653.69
2023-09-30 558.59 -720.44 -707.70
2023-06-30 585.65 -776.27 -764.20
2023-03-31 570.23 -906.00 -895.10
2022-12-31 563.24 -980.41 -971.23
2022-09-30 568.35 -1,015.09 -1,006.15
2022-06-30 540.33 -951.49 -945.15
2022-03-31 536.76 -888.06 -886.67
2021-12-31 507.86 -797.06 -796.70
2021-09-30 492.24 -700.31 -702.03
2021-06-30 489.50 -653.91 -658.68
2021-03-31 469.20 -524.93 -526.07
2020-12-31 429.90 -412.40 -407.24
2020-09-30 386.86 -352.51 -345.85
2020-06-30
2020-03-31
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-03-31
2024-12-31
2024-09-30 -41.63 -41.63
2024-06-30 -55.31 -55.31
2024-03-31 -57.60 -57.60
2023-12-31 -63.84 -63.84
2023-09-30 -69.12 -69.12
2023-06-30 -74.35 -74.35
2023-03-31 -86.58 -86.58
2022-12-31 -93.47 -93.47
2022-09-30 -96.35 -96.35
2022-06-30 -90.43 -90.43
2022-03-31 -84.99 -84.99
2021-12-31 -76.45 -76.45
2021-09-30 -67.41 -67.41
2021-06-30 -63.31 -63.31
2021-03-31 -63.86 -63.86
2020-12-31 -68.76 -68.76
2020-09-30 -92.37 -92.37
2020-06-30 -136.19 -136.19
2020-03-31 -144.83 -144.83
Arus Kas: Operasi, Investasi, Pendanaan
  • Nilai cash from operating activities untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -75.58 MM.
  • Nilai cash from investing activities untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -3.56 MM.
  • Nilai kas dari aktivitas pendanaan untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) per 2025 Mar 31 adalah -0.07 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-03-31 -75.58 -3.56 -0.07
2024-12-31 -92.26 -4.41 -0.07
2024-09-30 -127.34 -3.93 -1.91
2024-06-30 -144.48 -4.93 -47.80
2024-03-31 -182.85 -7.63 -48.80
2023-12-31 -255.78 -9.30 -48.83
2023-09-30 -307.47 -14.01 -57.00
2023-06-30 -395.52 -32.17 -13.78
2023-03-31 -425.59 1.49 -82.34
2022-12-31 -456.81 -7.46 -86.24
2022-09-30 -501.45 -69.40 -82.94
2022-06-30 -499.38 -121.34 -113.27
2022-03-31 -509.10 -219.64 -52.67
2021-12-31 -477.89 81.70 -52.90
2021-09-30 -456.20 112.24 22.36
2021-06-30 -359.85 -181.05 34.41
2021-03-31 -179.73 182.63 1,889.33
2020-12-31 -73.54 -109.31 2,165.72
2020-09-30 -33.02 -50.62 2,098.33
2020-06-30
2020-03-31
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Efektivitas Manajemen
  • roa untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.35.
  • roe untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.48.
  • roic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.55.
  • croic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.15.
  • ocroic untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.15.
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
2025-03-31 -0.35 -0.48 -0.55 -0.15 -0.15
2024-12-31 -0.41 -0.56 -0.57 -0.18 -0.17
2024-09-30 -0.49 -0.66 -0.72 -0.25 -0.18
2024-06-30 -0.42 -0.56 -0.80 -0.31 -0.25
2024-03-31 -0.45 -0.61 -0.80 -0.43 -0.35
2023-12-31 -0.41 -0.54 -0.80 -0.43 -0.35
2023-09-30 -0.41 -0.53 -0.77 -0.42 -0.40
2023-06-30 -0.52 -0.68 -0.77 -0.42 -0.40
2023-03-31 -0.46 -0.59 -0.82 -0.43 -0.39
2022-12-31 -0.41 -0.49 -0.74 -0.47 -0.37
2022-09-30 -0.39 -0.46 -0.74 -0.47 -0.37
2022-06-30 -0.35 -0.41 -0.63 -0.49 -0.33
2022-03-31 -0.30 -0.34 -0.51 -0.48 -0.29
2021-12-31 -0.26 -0.29 -0.41 -0.25 -0.21
2021-09-30 -0.25 -0.26 -0.32 -0.19 -0.16
2021-06-30 -0.22 -0.25 -0.29 -0.30 -0.16
2021-03-31 -0.49 -0.59 -0.21 0.71 -0.07
2020-12-31 -0.48 -0.62 -0.16 0.73 -0.03
2020-09-30 -0.13 0.74 -0.01
2020-06-30 -0.67 -0.09 0.87 -0.00
2020-03-31 -0.55 -0.21 -0.05 -0.14
Gross Margins
  • marjin kotor untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah 0.70.
  • marjin bersih untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.67.
  • marjin operasi untuk Burning Rock Biotech Limited - Depositary Receipt (Common Stock) pada 2025 Mar 31 adalah -0.63.
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
2025-03-31 0.70 -0.67 -0.63
2024-12-31 0.69 -0.84 -0.87
2024-09-30 0.68 -1.11 -1.14
2024-06-30 0.67 -1.13 -1.17
2024-03-31 0.69 -1.27 -1.29
2023-12-31 0.69 -1.27 -1.29
2023-09-30 0.70 -1.30 -1.33
2023-06-30 0.67 -1.30 -1.33
2023-03-31 0.67 -1.57 -1.59
2022-12-31 0.68 -1.77 -1.79
2022-09-30 0.68 -1.77 -1.79
2022-06-30 0.70 -1.75 -1.76
2022-03-31 0.72 -1.65 -1.65
2021-12-31 0.73 -1.57 -1.57
2021-09-30 0.73 -1.43 -1.42
2021-06-30 0.73 -1.35 -1.34
2021-03-31 0.74 -1.12 -1.12
2020-12-31 0.73 -0.95 -0.96
2020-09-30 0.70 -0.89 -0.91
2020-06-30 0.70 -0.68 -0.71
2020-03-31 0.70 -0.60 -0.63
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)1792267
Grupong Pang-industriya
SIC 8071 - Medical Laboratories
Other Listings
DE:6BU0
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista